Bridgeway Agency, Llc | |
4511 Ne County Road 219a Melrose FL 32666-6027 | |
(352) 727-9304 | |
Not Available |
Full Name | Bridgeway Agency, Llc |
---|---|
Speciality | Behavior Analyst |
Location | 4511 Ne County Road 219a, Melrose, Florida |
Authorized Official Name and Position | Kassandra Bryan (OWNER/BCBA) |
Authorized Official Contact | 3527279304 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Bridgeway Agency, Llc 4511 Ne County Road 219a Melrose FL 32666-6027 Ph: (352) 727-9304 | Bridgeway Agency, Llc 4511 Ne County Road 219a Melrose FL 32666-6027 Ph: (352) 727-9304 |
NPI Number | 1962156281 |
---|---|
Provider Enumeration Date | 02/06/2022 |
Last Update Date | 05/26/2022 |
Certification Date | 05/26/2022 |
Identifier | Type | State | Issuer |
---|---|---|---|
1962156281 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
News Archive
Chronic inflammation is increasingly a focus of research. A recent study has now identified differences in indicators of inflammation between novel diabetes subgroups. But what does this mean for the future?
The American Society for Dermatologic Surgery (ASDS) multispecialty Soft-tissue Fillers Guideline Task Force has released its evidence-based recommendations for physicians performing injectable filler procedures.
Various plants and their products are known to contain "bioactive" ingredients that can alleviate human diseases. These "phytocompounds" often contain restorative biological properties such as anti-cancerous, antioxidant, and anti-inflammatory effects.
More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests, digital rectal exams and ultrasounds at regular intervals to see if their tumors are growing. Nearly 400 men are now enrolled in the UCLA Active Surveillance program, the largest in Southern California.
Royal Philips and Netherlands-based Radboud university medical center today introduced a connected digital health prototype that enables people living with diabetes and their health care providers to make more confident care decisions while managing the complexity of diabetes self-care. In its first phase, the solution both organizations are developing will focus on patients living with diabetes type 1.
› Verified 5 days ago